Early Clinical Response in Community-acquired Bacterial Pneumonia: From Clinical Endpoint to Clinical Practice

BACKGROUND: Early clinical response (ECR) is a new endpoint to determine whether a drug should be approved for community-acquired bacterial pneumonia in the United States. The Omadacycline for Pneumonia Treatment In the Community (OPTIC) phase III study demonstrated noninferiority of omadacycline to...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramirez, Julio A, Tzanis, Evan, Curran, Marla, Noble, Robert, Chitra, Surya, Manley, Amy, Kirsch, Courtney, McGovern, Paul C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Supplement Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6669292/
https://www.ncbi.nlm.nih.gov/pubmed/31367741
http://dx.doi.org/10.1093/cid/ciz397

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6669292/
https://www.ncbi.nlm.nih.gov/pubmed/31367741
http://dx.doi.org/10.1093/cid/ciz397

Ejemplares similares